Fingerprint
Dive into the research topics of 'Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin
Noa E. Wijnen*, Joost B. Koedijk, Kim Klein, Maaike Luesink, Bianca F. Goemans, C. Michel Zwaan, Gertjan J.L. Kaspers
*Corresponding author for this work
Research output: Contribution to journal › Review article › Academic › peer-review
3
Citations
(Scopus)
79
Downloads
(Pure)